The Envision Health Consulting Difference
Envision Health Consultant Pharmacists are skilled health care professionals who have specialized training in the medication-related needs of seniors. Envision Health Consultants complete comprehensive consultations that provide thorough, review of each resident’s medications — prescription, over-the-counter, herbal, and nutritional. Envision Health Consultants are experts in the regulatory requirements for Skilled and Assisted Living, as well as behavioral health and correctional facilities and have experience aiding facilities in obtaining JACHO certification as well preventing survey issues.
Educational Services
Besides being the leader in pharmacy consulting services, Envision Health Consulting also offers continuing education for not only pharmacists but nursing professionals and healthcare administrators as well.
Envision Health Consulting currently offers a large number of classes of continuing education which includes a wide array of topics including the state required, Medication Errors and Human Trafficking. Envision will gladly come to your place of business and set up classes for your staff as well as one on one instruction. Both local and regional programs are also available.
Long Term Care & Clinical Consulting
Envision Health Consulting prides itself on being a leader in Skilled Nursing and Assisted Living Consultant Services and goes well beyond the mandatory services. Our pharmacists provide visit reports based on the findings of each inspection.
Our recommendations are individualized to each resident and delivered directly to the facility and prescriber. We also provide a summary of recommendations for easy tracking. All Consultant reports are posted to this website for HIPAA secure access by the pharmacy and the facility any time 24/7.
“Our goal is to provide the BEST pharmacy consultant care to facility residents, and provide all facility, medical staffs, and provider pharmacies with the best level of support possible”
Latest News
View our latest news and updates!
FDA Approves First Drug for Steroid-Refractory Acute Graft-Versus-Host Disease (GVHD)
In 2019 Incyte’s drug Jakafi (ruxolitinib) became the first medication FDA approved for the treatment of steroid-refractory acute GVHD in...
Read MoreHot off the Press: FDA Approves New Treatment for Heart Failure with Reduced Ejection Fraction
Hot off the Press: FDA Approves New Treatment for Heart Failure with Reduced Ejection Fraction On May 5, 2020 after...
Read MoreResearchers provide new insights into hearing loss
Researchers provide new insights into hearing loss Between one-quarter and one-third of individuals older than 65 experience age related hearing...
Read MoreHow the Elderly Can Manage the Mental Health Impacts of the COVID-19 Pandemic
Due to the strict precautions many geriatric adults are being recommended to take by the CDC, for many patients this...
Read More